To determine whether augmenting autophagy could reverse the overaccumulation of p62 following CIN treatment, we used RAPA, which is an autophagy activator and a specific mTOR inhibitor. This evidence concerns the gene SQSTM1 and cervical squamous intraepithelial neoplasia.